Search
 
NEWS
 

Dostarlimab Combination Shows Improved Endometrial Cancer Patient Survival at Trial Interim Analysis - Pharmacy Times

 
 
Following the positive phase 3 results, GSK anticipates regulatory submissions in the first half of 2023. - READ MORE
By Pharmacy Times
Thu, 15 Dec 2022 12:58:42 GMT
 
PREVIOUS NEXT
CORRECTING and REPLACING Electra Acquires New Cobalt Project and Provides Update on Exploration Activities in Idaho - Yahoo Finance
Ruby Cruz age: How old is Willow’s Kit actress? - HITC - Football, Gaming, Movies, TV, Music
Planet Rugby Awards: France, Etzebeth, Tui, Italy, La Rochelle and more - planetrugby.com
RUBY: Setting the Record Straight | Opinion - The Sentinel-Echo
Tickets now on sale for 2023 Flav-R-Pac NHRA Northwest Nationals in Seattle - NHRA.com
Craig R. Weise of South Hadley accused of murdering father, attempting to set house on fire - MassLive.com
Patricia R. Robbins | News, Sports, Jobs - Nashua Telegraph
R Ashwin Is India’s Most Underrated All-Rounder; People Know It But Won’t Acknowledge - MensXP.com
Tagged: #Dostarlimab #Combination #Shows #Improved #Endometrial #Cancer #Patient #Survival #Trial #Interim #Analysis #Pharmacy #Times
ADD COMMENT
Topic
Name
8+9 =